1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Deep, S.
Walker III, K.P.
Shu, Z.
Hinck, A.P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
42
10126
10139
10.1021/bi034366a
12939140
Solution structure and backbone dynamics of the TGF-beta type II receptor extracellular domain
2003
10.2210/pdb1plo/pdb
pdb_00001plo
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
13810.606
TGF-beta receptor type II
2.7.1.37
N19A
1
man
polymer
TGFR-2, TGF-beta type II receptor
no
no
VTDNAGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAA
SPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD
VTDNAGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAA
SPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
TGFBR2
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21(DE3)
Plasmid
pET32a
database_2
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-09-23
1
1
2008-04-29
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
Backbone and Sidechain 1H, 13C, and 15N NMR Chemical Shift Assignments
RCSB
Y
RCSB
2003-06-08
REL
REL
This structure was determined by refining simultaneously against NOE, J-coupling, dihedral angle,
and residual dipolar coupling constraints
structures with acceptable covalent geometry, structures with favorable non-bond energy,
structures with the least restraint violations, structures with the lowest energy
50
10
3D_15N-separated_NOESY
3D_13C-separated_NOESY
4D_13C-separated_NOESY
3D 15N edited, 13C-edited 1H-1H noesy
3D 15N-edited,15N-edited 1H-1H noesy
1H-15H 1-bond residual dipolar coupling (2D IPAP-HSQC)
13C-13CO residual dipolar coupling (3D (HA)CA(CO)NH
13Calpha-13CO residual dipolar coupling (3D Ca-coupled HNCO)
25mM sodium acetate, 25mM NaCl, pH 5.5
5.5
ambient
300
K
25mM sodium acetate, 25mM NaCl
5.1
ambient
300
K
25mM sodium acetate, 25mM NaCl
5.5
ambient
313
K
structures are based on a total of 1583 constraints,
1168 are NOE distance,
138 are dihedredral angle,
58 are 3JHNHa coupling constant,
219 are residual dipolar couplings,
substructure distance geometry, full structure distance geometry-simulated annealing;
torsion angle dynamics
1
fewest violations, lowest energy
1mM ecTbR2 U-15N, 25mM sodium acetate, 25mM NaCl, 95% H2O, 5% D2O
95% H2O/5% D2O
1mM ecTbR2 U-15N, 13C, 25mM sodium acetate, 25mM NaCl, 95% H2O, 5% D2O
95% H2O/5% D2O
1mM ecTbR2 U-15N, 13C, 25mM sodium acetate, 25mM NaCl, 99.99% D2O
99.99% D2O
1mM ecTbR2 U-15N, 25mM sodium acetate, 25mM NaCl, 4% (w/v) 1,2-di-O-hexyl-sn-glycero-3-phosphocholine (6-O-PC) and 1,2-di-O-tetradecyl-sn-glycero-3-phosphocholine (14-O-PC) mixed in a molar ratio of 1:3, 95% H2O, 5% D2O
95% H2O/5% D2O
1mM ecTbR2 U-15N, 13C, 25mM sodium acetate, 25mM NaCl, 4% (w/v) 1,2-di-O-hexyl-sn-glycero-3-phosphocholine (6-O-PC) and 1,2-di-O-tetradecyl-sn-glycero-3-phosphocholine (14-O-PC) mixed in a molar ratio of 1:3, 95% H2O, 5% D2O
95% H2O/5% D2O
Clore, G.M., Kuszewski, J., Schwieters, C.D., Tjandra, N.
refinement
XPLOR_NIH
1.06
600
Bruker
DRX
500
Bruker
AVANCE
VAL
15
n
1
VAL
15
A
THR
16
n
2
THR
16
A
ASP
17
n
3
ASP
17
A
ASN
18
n
4
ASN
18
A
ALA
19
n
5
ALA
19
A
GLY
20
n
6
GLY
20
A
ALA
21
n
7
ALA
21
A
VAL
22
n
8
VAL
22
A
LYS
23
n
9
LYS
23
A
PHE
24
n
10
PHE
24
A
PRO
25
n
11
PRO
25
A
GLN
26
n
12
GLN
26
A
LEU
27
n
13
LEU
27
A
CYS
28
n
14
CYS
28
A
LYS
29
n
15
LYS
29
A
PHE
30
n
16
PHE
30
A
CYS
31
n
17
CYS
31
A
ASP
32
n
18
ASP
32
A
VAL
33
n
19
VAL
33
A
ARG
34
n
20
ARG
34
A
PHE
35
n
21
PHE
35
A
SER
36
n
22
SER
36
A
THR
37
n
23
THR
37
A
CYS
38
n
24
CYS
38
A
ASP
39
n
25
ASP
39
A
ASN
40
n
26
ASN
40
A
GLN
41
n
27
GLN
41
A
LYS
42
n
28
LYS
42
A
SER
43
n
29
SER
43
A
CYS
44
n
30
CYS
44
A
MET
45
n
31
MET
45
A
SER
46
n
32
SER
46
A
ASN
47
n
33
ASN
47
A
CYS
48
n
34
CYS
48
A
SER
49
n
35
SER
49
A
ILE
50
n
36
ILE
50
A
THR
51
n
37
THR
51
A
SER
52
n
38
SER
52
A
ILE
53
n
39
ILE
53
A
CYS
54
n
40
CYS
54
A
GLU
55
n
41
GLU
55
A
LYS
56
n
42
LYS
56
A
PRO
57
n
43
PRO
57
A
GLN
58
n
44
GLN
58
A
GLU
59
n
45
GLU
59
A
VAL
60
n
46
VAL
60
A
CYS
61
n
47
CYS
61
A
VAL
62
n
48
VAL
62
A
ALA
63
n
49
ALA
63
A
VAL
64
n
50
VAL
64
A
TRP
65
n
51
TRP
65
A
ARG
66
n
52
ARG
66
A
LYS
67
n
53
LYS
67
A
ASN
68
n
54
ASN
68
A
ASP
69
n
55
ASP
69
A
GLU
70
n
56
GLU
70
A
ASN
71
n
57
ASN
71
A
ILE
72
n
58
ILE
72
A
THR
73
n
59
THR
73
A
LEU
74
n
60
LEU
74
A
GLU
75
n
61
GLU
75
A
THR
76
n
62
THR
76
A
VAL
77
n
63
VAL
77
A
CYS
78
n
64
CYS
78
A
HIS
79
n
65
HIS
79
A
ASP
80
n
66
ASP
80
A
PRO
81
n
67
PRO
81
A
LYS
82
n
68
LYS
82
A
LEU
83
n
69
LEU
83
A
PRO
84
n
70
PRO
84
A
TYR
85
n
71
TYR
85
A
HIS
86
n
72
HIS
86
A
ASP
87
n
73
ASP
87
A
PHE
88
n
74
PHE
88
A
ILE
89
n
75
ILE
89
A
LEU
90
n
76
LEU
90
A
GLU
91
n
77
GLU
91
A
ASP
92
n
78
ASP
92
A
ALA
93
n
79
ALA
93
A
ALA
94
n
80
ALA
94
A
SER
95
n
81
SER
95
A
PRO
96
n
82
PRO
96
A
LYS
97
n
83
LYS
97
A
CYS
98
n
84
CYS
98
A
ILE
99
n
85
ILE
99
A
MET
100
n
86
MET
100
A
LYS
101
n
87
LYS
101
A
GLU
102
n
88
GLU
102
A
LYS
103
n
89
LYS
103
A
LYS
104
n
90
LYS
104
A
LYS
105
n
91
LYS
105
A
PRO
106
n
92
PRO
106
A
GLY
107
n
93
GLY
107
A
GLU
108
n
94
GLU
108
A
THR
109
n
95
THR
109
A
PHE
110
n
96
PHE
110
A
PHE
111
n
97
PHE
111
A
MET
112
n
98
MET
112
A
CYS
113
n
99
CYS
113
A
SER
114
n
100
SER
114
A
CYS
115
n
101
CYS
115
A
SER
116
n
102
SER
116
A
SER
117
n
103
SER
117
A
ASP
118
n
104
ASP
118
A
GLU
119
n
105
GLU
119
A
CYS
120
n
106
CYS
120
A
ASN
121
n
107
ASN
121
A
ASP
122
n
108
ASP
122
A
ASN
123
n
109
ASN
123
A
ILE
124
n
110
ILE
124
A
ILE
125
n
111
ILE
125
A
PHE
126
n
112
PHE
126
A
SER
127
n
113
SER
127
A
GLU
128
n
114
GLU
128
A
GLU
129
n
115
GLU
129
A
TYR
130
n
116
TYR
130
A
ASN
131
n
117
ASN
131
A
THR
132
n
118
THR
132
A
SER
133
n
119
SER
133
A
ASN
134
n
120
ASN
134
A
PRO
135
n
121
PRO
135
A
ASP
136
n
122
ASP
136
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
28
A
N
CYS
14
A
O
SER
52
A
O
SER
38
A
N
ARG
34
A
N
ARG
20
A
O
LEU
74
A
O
LEU
60
A
O
HIS
79
A
O
HIS
65
A
N
VAL
60
A
N
VAL
46
A
N
LYS
67
A
N
LYS
53
A
O
THR
109
A
O
THR
95
A
N
ARG
34
A
N
ARG
20
A
O
LEU
74
A
O
LEU
60
A
O
HIS
79
A
O
HIS
65
A
N
VAL
60
A
N
VAL
46
A
N
CYS
61
A
N
CYS
47
A
O
CYS
115
A
O
CYS
101
A
N
CYS
44
A
N
CYS
30
A
O
ILE
124
A
O
ILE
110
1
A
A
O
H
CYS
SER
28
52
1.53
1
A
A
H
O
VAL
HIS
60
79
1.59
1
A
A
H
O
ASN
ASN
68
71
1.59
2
A
A
HE3
OD2
LYS
ASP
29
122
0.89
2
A
A
HE3
CG
LYS
ASP
29
122
0.99
2
A
A
CE
OD2
LYS
ASP
29
122
1.09
2
A
A
HE2
OD2
LYS
ASP
29
122
1.11
2
A
A
O
OD1
ASN
ASP
68
69
1.37
2
A
A
HE3
OD1
LYS
ASP
29
122
1.47
2
A
A
O
HG
CYS
SER
48
49
1.54
2
A
A
O
H
CYS
SER
28
52
1.56
2
A
A
CE
CG
LYS
ASP
29
122
1.66
2
A
A
O
OD1
THR
ASP
37
39
1.71
2
A
A
CD
OD1
LYS
ASP
29
122
1.90
2
A
A
CE
OD1
LYS
ASP
29
122
1.99
2
A
A
CD
CG
LYS
ASP
29
122
2.19
3
A
A
OE1
H
GLU
THR
108
109
0.89
3
A
A
CD
H
GLU
THR
108
109
1.41
3
A
A
OE1
N
GLU
THR
108
109
1.54
3
A
A
O
H
CYS
SER
28
52
1.57
3
A
A
H
O
ALA
CYS
63
113
1.58
3
A
A
O
OE2
LYS
GLU
67
108
1.82
5
A
A
OD1
H
ASP
VAL
32
33
1.09
5
A
A
CG
H
ASP
VAL
32
33
1.39
5
A
A
OD1
N
ASP
VAL
32
33
1.39
5
A
A
H
O
SER
ASP
46
122
1.53
5
A
A
OD1
N
ASP
ASN
17
18
1.68
5
A
A
C
OD1
CYS
ASP
38
39
1.80
5
A
A
O
OD1
THR
ASP
37
39
1.83
6
A
A
OE1
H
GLU
THR
108
109
1.33
6
A
A
CD
H
GLU
THR
108
109
1.48
6
A
A
O
OE2
LYS
GLU
67
108
1.74
7
A
A
OD1
H
ASP
VAL
32
33
0.87
7
A
A
OE1
N
GLU
TYR
129
130
1.20
7
A
A
OD1
N
ASP
VAL
32
33
1.20
7
A
A
OE1
H
GLU
THR
108
109
1.46
7
A
A
CG
H
ASP
VAL
32
33
1.46
7
A
A
HG2
OD2
GLU
ASP
59
80
1.48
7
A
A
H
O
VAL
HIS
60
79
1.57
7
A
A
O
H
VAL
HIS
60
79
1.59
7
A
A
H
O
ARG
LEU
34
74
1.60
8
A
A
HE3
OD2
LYS
ASP
29
122
0.24
8
A
A
HZ1
OD1
LYS
ASP
29
122
0.77
8
A
A
CE
OD2
LYS
ASP
29
122
1.16
8
A
A
HE3
CG
LYS
ASP
29
122
1.42
8
A
A
NZ
OD1
LYS
ASP
29
122
1.47
8
A
A
H
O
VAL
HIS
60
79
1.59
8
A
A
OE1
HE3
GLU
LYS
55
56
1.60
8
A
A
CE
CG
LYS
ASP
29
122
1.69
8
A
A
CE
OD1
LYS
ASP
29
122
1.92
8
A
A
CD
OD1
LYS
ASP
29
122
1.93
8
A
A
NZ
CG
LYS
ASP
29
122
1.93
8
A
A
CD
CG
LYS
ASP
29
122
2.05
8
A
A
CD
OD2
LYS
ASP
29
122
2.09
8
A
A
NZ
OD2
LYS
ASP
29
122
2.14
9
A
A
OD1
H
ASP
GLU
69
70
0.70
9
A
A
OE1
H
GLU
THR
108
109
1.00
9
A
A
OD1
N
ASP
GLU
69
70
1.12
9
A
A
O
OE2
LYS
GLU
67
108
1.25
9
A
A
OD1
H
ASP
VAL
32
33
1.26
9
A
A
CD
H
GLU
THR
108
109
1.37
9
A
A
OD1
N
ASP
VAL
32
33
1.48
9
A
A
CG
H
ASP
VAL
32
33
1.49
9
A
A
CG
H
ASP
GLU
69
70
1.55
9
A
A
H
O
LYS
PHE
103
110
1.57
9
A
A
OE1
N
GLU
THR
108
109
1.61
9
A
A
C
OE2
LYS
GLU
67
108
2.13
10
A
A
HE3
OD2
LYS
ASP
29
122
0.58
10
A
A
HB2
OE2
LYS
GLU
105
108
0.89
10
A
A
CE
OD2
LYS
ASP
29
122
1.04
10
A
A
HB2
CD
LYS
GLU
105
108
1.04
10
A
A
CB
OE2
LYS
GLU
105
108
1.05
10
A
A
OE2
H
GLU
THR
129
132
1.10
10
A
A
HE2
OD2
LYS
ASP
29
122
1.39
10
A
A
HB3
OE2
LYS
GLU
105
108
1.42
10
A
A
HE3
CG
LYS
ASP
29
122
1.44
10
A
A
HB2
OE1
LYS
GLU
105
108
1.51
10
A
A
OE1
N
GLU
TYR
129
130
1.52
10
A
A
OG
H
SER
ASN
127
131
1.55
10
A
A
HG
O
SER
LYS
95
97
1.56
10
A
A
H
O
LYS
PHE
103
110
1.58
10
A
A
CG
OE2
LYS
GLU
105
108
1.70
10
A
A
CB
CD
LYS
GLU
105
108
1.83
10
A
A
OE2
N
GLU
THR
129
132
2.03
10
A
A
CE
CG
LYS
ASP
29
122
2.05
10
A
A
CD
OD2
LYS
ASP
29
122
2.13
10
A
A
CD
OE2
LYS
GLU
105
108
2.19
1
A
ARG
34
0.240
SIDE CHAIN
1
A
ARG
66
0.215
SIDE CHAIN
2
A
ARG
34
0.240
SIDE CHAIN
2
A
ARG
66
0.315
SIDE CHAIN
3
A
ARG
34
0.316
SIDE CHAIN
3
A
ARG
66
0.253
SIDE CHAIN
4
A
ARG
34
0.297
SIDE CHAIN
4
A
ARG
66
0.318
SIDE CHAIN
5
A
ARG
34
0.313
SIDE CHAIN
5
A
ARG
66
0.255
SIDE CHAIN
6
A
ARG
34
0.298
SIDE CHAIN
6
A
ARG
66
0.315
SIDE CHAIN
7
A
ARG
34
0.245
SIDE CHAIN
7
A
ARG
66
0.295
SIDE CHAIN
8
A
ARG
34
0.262
SIDE CHAIN
8
A
ARG
66
0.311
SIDE CHAIN
9
A
ARG
34
0.286
SIDE CHAIN
9
A
ARG
66
0.235
SIDE CHAIN
10
A
ARG
34
0.169
SIDE CHAIN
10
A
ARG
66
0.315
SIDE CHAIN
1
A
VAL
22
-178.60
34.78
1
A
ASP
32
68.84
-142.71
1
A
ASP
39
-90.70
-95.57
1
A
GLN
41
-77.88
-143.10
1
A
LYS
42
55.32
102.46
1
A
SER
43
43.51
84.23
1
A
CYS
48
-147.89
-42.96
1
A
VAL
60
-121.78
-166.94
1
A
ASP
69
56.55
-77.58
1
A
GLU
91
-159.96
7.88
1
A
GLU
102
47.10
149.53
1
A
CYS
113
-168.71
114.82
1
A
ASP
118
-38.27
-101.17
1
A
SER
127
-156.55
3.95
1
A
GLU
128
58.36
-74.54
2
A
ALA
19
52.90
174.46
2
A
ALA
21
-172.20
-37.63
2
A
ASP
32
80.89
-161.91
2
A
ASN
40
32.66
95.84
2
A
GLN
41
-160.86
-86.19
2
A
LYS
42
-156.18
-55.57
2
A
VAL
60
-114.96
-163.01
2
A
ASP
69
66.99
-66.73
2
A
GLU
70
-140.48
-21.90
2
A
PRO
81
-82.38
49.41
2
A
ASP
87
70.46
30.90
2
A
GLU
91
-162.24
57.10
2
A
ASP
92
-148.54
-0.86
2
A
MET
100
55.11
99.29
2
A
GLU
102
25.04
118.37
2
A
CYS
113
-178.90
146.23
2
A
GLU
119
53.00
78.87
2
A
GLU
128
-157.51
-72.79
2
A
TYR
130
-179.63
-29.40
2
A
ASN
131
-172.29
58.01
2
A
THR
132
54.10
-92.58
3
A
ASP
32
80.43
-160.46
3
A
ASN
40
34.08
95.12
3
A
GLN
41
-161.92
-84.90
3
A
LYS
42
-156.85
-57.43
3
A
SER
46
60.34
148.08
3
A
ASP
69
64.39
-68.49
3
A
GLU
70
-131.66
-36.15
3
A
HIS
86
69.48
-51.72
3
A
ASP
87
-160.28
-18.46
3
A
GLU
91
-159.92
64.47
3
A
ASP
92
-151.12
3.85
3
A
ILE
99
-66.94
75.59
3
A
GLU
119
54.26
119.89
3
A
CYS
120
-159.91
20.21
3
A
SER
127
-158.67
-65.12
3
A
GLU
128
59.70
-80.53
3
A
GLU
129
-142.14
10.16
3
A
ASN
134
54.24
80.06
4
A
ASP
17
-153.58
77.52
4
A
VAL
22
-131.85
-136.33
4
A
LYS
23
62.35
135.15
4
A
ASP
32
71.05
-154.66
4
A
ASP
39
-92.05
-71.19
4
A
ASN
40
32.40
100.86
4
A
LYS
42
-154.58
-70.31
4
A
VAL
60
-110.41
-161.36
4
A
ASP
69
-165.30
-37.13
4
A
GLU
91
-160.60
9.86
4
A
GLU
102
45.89
155.31
4
A
PRO
106
-84.94
40.82
4
A
ASP
118
-39.74
-112.94
4
A
GLU
119
-79.75
46.23
4
A
CYS
120
-89.49
35.19
4
A
GLU
128
59.04
-80.78
4
A
GLU
129
-91.42
52.01
4
A
TYR
130
35.44
60.63
4
A
THR
132
55.90
-86.75
5
A
ASP
17
51.81
-159.43
5
A
ALA
19
-58.53
174.16
5
A
VAL
22
57.62
-123.77
5
A
ASP
32
74.21
-145.36
5
A
ASP
39
28.37
-136.53
5
A
SER
49
-158.14
31.87
5
A
VAL
60
-111.08
-167.08
5
A
GLU
70
86.37
45.08
5
A
GLU
91
-162.46
15.36
5
A
MET
100
59.42
91.66
5
A
CYS
113
-174.40
135.41
5
A
SER
117
-138.42
-76.91
5
A
ASP
118
165.47
128.22
5
A
CYS
120
-86.07
35.81
5
A
SER
127
-157.99
29.36
5
A
GLU
128
55.88
-85.93
5
A
TYR
130
52.50
75.35
6
A
LYS
23
-101.22
-67.35
6
A
PHE
24
54.04
173.75
6
A
PRO
25
-71.13
-90.42
6
A
CYS
28
-162.04
-161.83
6
A
ASP
32
69.56
-151.13
6
A
GLN
41
-162.55
-32.07
6
A
LYS
42
-153.63
-145.52
6
A
SER
49
-157.66
19.91
6
A
GLU
55
1.25
-59.11
6
A
VAL
60
-112.40
-169.19
6
A
ASP
69
67.76
-68.20
6
A
GLU
70
-140.63
-17.99
6
A
PRO
81
-75.45
-147.63
6
A
LYS
82
66.49
-58.37
6
A
GLU
91
-163.56
13.86
6
A
GLU
102
45.26
157.18
6
A
PRO
106
-78.57
23.77
6
A
CYS
113
-162.82
112.16
6
A
GLU
119
57.36
121.36
6
A
CYS
120
-141.31
-22.95
6
A
SER
127
-158.13
-36.74
6
A
GLU
128
54.99
-102.81
6
A
ASN
131
-54.90
88.68
6
A
ASN
134
54.68
71.17
7
A
THR
16
64.88
-68.36
7
A
PHE
24
56.63
164.59
7
A
ASP
32
73.55
-150.36
7
A
ARG
34
-116.76
-165.10
7
A
CYS
38
-63.96
72.63
7
A
SER
43
81.99
154.47
7
A
ASP
69
66.79
-68.55
7
A
LEU
90
-161.76
79.79
7
A
MET
100
-68.92
88.10
7
A
GLU
102
74.30
129.57
7
A
ASP
118
-40.50
-105.49
7
A
GLU
128
53.17
-89.50
7
A
ASN
131
-93.91
30.64
8
A
ALA
21
66.73
-61.14
8
A
ASP
32
67.87
-147.89
8
A
CYS
38
-179.69
64.04
8
A
ASN
40
-178.58
126.67
8
A
GLN
41
-79.81
20.97
8
A
SER
43
81.30
156.68
8
A
ASP
69
57.74
-76.32
8
A
ILE
89
-85.11
-142.58
8
A
LEU
90
-161.60
-50.97
8
A
ASP
92
-149.76
-13.69
8
A
GLU
102
78.38
127.95
8
A
GLU
119
59.62
133.06
8
A
CYS
120
-175.41
-24.10
8
A
SER
127
-157.85
53.48
8
A
GLU
128
55.39
-92.01
8
A
GLU
129
-101.01
-61.34
8
A
TYR
130
-169.00
72.77
8
A
THR
132
45.10
24.47
8
A
SER
133
177.08
-33.03
8
A
ASN
134
53.96
73.61
9
A
PHE
24
61.47
137.93
9
A
ASP
32
70.02
-150.23
9
A
CYS
38
-62.02
90.51
9
A
ASP
39
-112.83
-159.88
9
A
ASN
40
37.67
-96.34
9
A
GLN
41
-163.86
-130.74
9
A
LYS
42
63.52
-5.04
9
A
SER
43
74.92
155.18
9
A
ASP
69
55.12
-82.13
9
A
GLU
91
-162.81
9.61
9
A
GLU
102
75.84
126.60
9
A
GLU
119
47.28
79.66
9
A
SER
127
-157.93
-126.03
9
A
GLU
128
58.65
-86.39
9
A
SER
133
82.38
-21.59
9
A
ASN
134
30.35
54.36
10
A
ASN
18
60.44
152.10
10
A
LYS
23
-67.74
-148.55
10
A
PHE
24
61.74
164.75
10
A
PHE
30
-115.87
73.38
10
A
ASP
32
-41.73
-142.85
10
A
ASP
39
-174.63
-139.60
10
A
GLN
41
-162.73
-90.77
10
A
LYS
42
-156.30
46.52
10
A
SER
43
76.66
156.81
10
A
SER
49
-158.56
29.31
10
A
GLU
55
1.78
-58.35
10
A
VAL
60
-113.68
-166.86
10
A
ASP
69
64.58
-71.15
10
A
GLU
91
-159.60
31.20
10
A
GLU
102
77.83
121.54
10
A
ASP
118
-40.49
-111.37
10
A
GLU
128
59.78
-76.03
10
A
TYR
130
53.72
72.74
10
A
THR
132
50.16
-100.16
TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN
1
N
N
disulf
2.018
A
CYS
28
A
SG
CYS
14
1_555
A
CYS
61
A
SG
CYS
47
1_555
disulf
2.018
A
CYS
31
A
SG
CYS
17
1_555
A
CYS
48
A
SG
CYS
34
1_555
disulf
2.018
A
CYS
38
A
SG
CYS
24
1_555
A
CYS
44
A
SG
CYS
30
1_555
disulf
2.019
A
CYS
54
A
SG
CYS
40
1_555
A
CYS
78
A
SG
CYS
64
1_555
disulf
2.019
A
CYS
98
A
SG
CYS
84
1_555
A
CYS
113
A
SG
CYS
99
1_555
disulf
2.022
A
CYS
115
A
SG
CYS
101
1_555
A
CYS
120
A
SG
CYS
106
1_555
Cytokine receptor
Three-Finger Toxin Fold, Cytokine receptor
TGFR2_HUMAN
UNP
1
38
P37173
VTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAA
SPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD
38
159
1PLO
15
136
P37173
A
1
1
122
1
ASN
engineered mutation
ALA
19
1PLO
A
P37173
UNP
42
5
2
4
4
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LEU
27
A
LEU
13
A
LYS
29
A
LYS
15
A
THR
51
A
THR
37
A
ILE
53
A
ILE
39
A
ASP
32
A
ASP
18
A
PHE
35
A
PHE
21
A
ILE
72
A
ILE
58
A
HIS
79
A
HIS
65
A
VAL
60
A
VAL
46
A
LYS
67
A
LYS
53
A
THR
109
A
THR
95
A
PHE
110
A
PHE
96
A
ASP
32
A
ASP
18
A
PHE
35
A
PHE
21
A
ILE
72
A
ILE
58
A
HIS
79
A
HIS
65
A
VAL
60
A
VAL
46
A
LYS
67
A
LYS
53
A
SER
114
A
SER
100
A
CYS
115
A
CYS
101
A
CYS
44
A
CYS
30
A
MET
45
A
MET
31
A
ASN
123
A
ASN
109
A
ILE
124
A
ILE
110